Habermann, T. M., Wang, S. S., Maurer, M. J., Morton, L. M., Lynch, C. F., Ansell, S. M., . . . Cerhan, J. R. (2008). Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. American Society of Hematology.
Chicago Style CitationHabermann, Thomas M., et al. Host Immune Gene Polymorphisms in Combination With Clinical and Demographic Factors Predict Late Survival in Diffuse Large B-cell Lymphoma Patients in the Pre-rituximab Era. American Society of Hematology, 2008.
Cita MLAHabermann, Thomas M., et al. Host Immune Gene Polymorphisms in Combination With Clinical and Demographic Factors Predict Late Survival in Diffuse Large B-cell Lymphoma Patients in the Pre-rituximab Era. American Society of Hematology, 2008.